On May 1, 2014, Oncothyreon Inc. (NASDAQ:ONTY) issued a press release and will hold a conference call regarding the Company’s financial results for the quarter ended March 31, 2014. Oncothyreon Inc. (USA) (NASDAQ:ONTY) weekly performance is 0.76%. On last trading day company shares ended up $2.65. Analysts mean target price for the company is $5.33. Oncothyreon Inc. (USA) (NASDAQ:ONTY) distance from 50-day simple moving average (SMA50) is -13.17%.
ZELTIQ Aesthetics (NASDAQ:ZLTQ)’s stock had its “neutral” rating reaffirmed by equities research analysts at JPMorgan Chase & Co. Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ) shares fell -5.23% in last trading session and ended the day on $15.94. ZLTQ gross Margin is 70.70% and its return on assets is -22.70%.Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ) quarterly performance is -16.68%.
Fonar Corp. (NASDAQ:FONR) reported Q3 EPS of $0.26, versus $0.17 reported last year. Revenue for the quarter came in at $17.04 million, versus $11.64 million reported last year. Fonar Corporation (NASDAQ:FONR) shares moved down -18.97% in last trading session and was closed at $14.27, while trading in range of $13.44 – $15.95. Fonar Corporation (NASDAQ:FONR) year to date (YTD) performance is -32.72%.
Derma Sciences, Inc. (NASDAQ:DSCI), a tissue regeneration company focused on advanced wound and burn care reported financial and operating results for the three months ended March 31, 2014. Total net sales increased 5.3% to $19.8 million. Derma Sciences Inc. (NASDAQ:DSCI) ended the last trading day at $8.56. Company weekly volatility is calculated as 5.18% and price to cash ratio as 9.80.Derma Sciences Inc. (NASDAQ:DSCI) showed a negative weekly performance of -10.83%.
Reckitt Benckiser Group PLC (OTCMKTS:RBGLY) Thursday said Gareth Hill, a divisional vice president, sold 190,000 shares having exercised options for the shares under the company share plan at a price of GBP49.0356 each. On last trading day Reckitt Benckiser Group PLC (OTCMKTS:RBGLY) shares ended up $16.70.